Compare CRAI & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRAI | CLOV |
|---|---|---|
| Founded | 1965 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 1998 | 2020 |
| Metric | CRAI | CLOV |
|---|---|---|
| Price | $160.05 | $1.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $245.00 | $2.90 |
| AVG Volume (30 Days) | 172.6K | ★ 5.4M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | 20.77 | ★ 38.03 |
| EPS | ★ 8.14 | N/A |
| Revenue | $751,583,000.00 | ★ $1,924,308,000.00 |
| Revenue This Year | $7.82 | $52.59 |
| Revenue Next Year | $5.14 | $15.37 |
| P/E Ratio | $20.23 | ★ N/A |
| Revenue Growth | 9.33 | ★ 40.34 |
| 52 Week Low | $149.96 | $1.58 |
| 52 Week High | $227.29 | $3.92 |
| Indicator | CRAI | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 44.48 | 52.01 |
| Support Level | $152.25 | $1.58 |
| Resistance Level | $164.70 | $2.78 |
| Average True Range (ATR) | 6.04 | 0.10 |
| MACD | 1.19 | 0.03 |
| Stochastic Oscillator | 40.97 | 80.23 |
CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.